The problem I see with this test is that it is purely business model, no tech or fixed investment required. If CVS found it interesting, they could trial it tri

The problem I see with this test is that it is purely business model, no tech or fixed investment required. If CVS found it interesting, they could trial it trivially themselves, right? Disclaimer: not an expert in this market, so tell me where Theranos could have brought an innovation that isn't easily replicated to the test.